Summary & Overview
HCPCS H0003: Alcohol and/or Drug Screening, Laboratory Analysis
HCPCS Level II code H0003 designates laboratory analysis for alcohol and/or drug screening and is widely used across clinical and behavioral health settings to confirm substance exposure or monitor treatment adherence. The code captures toxicology testing performed on patient specimens and is relevant to emergency departments, inpatient and outpatient hospital laboratories, independent diagnostic labs, and substance use treatment programs. Nationally, accurate coding of H0003 supports clinical decision-making, reporting, and payer billing for diagnostic toxicology services.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what H0003 represents, common sites of service, and the clinical context for laboratory-based substance screening. The publication also summarizes typical reimbursement benchmarks, billing nuances, and recent policy considerations that affect coverage and claim adjudication for laboratory toxicology testing. This resource is intended to help coding, billing, and compliance teams understand where H0003 fits within service lines and payer practices.
Billing Code Overview
HCPCS Level II code H0003 describes alcohol and/or drug screening consisting of laboratory analysis of specimens for the presence of alcohol and/or drugs. This service type is toxicology laboratory testing performed on biological specimens to detect and quantify alcohol and/or controlled substances.
Typical site of service: clinical laboratory or other licensed laboratory setting, including hospital laboratories and independent diagnostic testing facilities where specimen collection and analytic testing occur.
Clinical & Coding Specifications
Clinical Context
A 34-year-old patient presents to an outpatient substance use treatment clinic for intake evaluation after self-reporting heavy alcohol use and occasional opioid use. The clinic orders a laboratory alcohol and drug screen to confirm recent substance use prior to initiating a medication-assisted treatment plan and to document baseline toxicology. The patient provides urine and blood specimens; the laboratory performs immunoassay screening followed by confirmatory gas chromatography–mass spectrometry (GC-MS) or liquid chromatography–tandem mass spectrometry (LC-MS/MS) for positive results. Results are used in the clinical workflow to guide counseling, medication selection, safety planning, and documentation for treatment eligibility and insurance billing. Typical sites of service include outpatient clinics, community behavioral health centers, emergency departments, and hospital inpatient units when screening is required for acute care or admission. Common scenarios include intake for substance use disorder treatment, pre-procedural screening when alcohol/drug use is a concern, workplace testing referrals, and monitoring during ongoing treatment programs.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard service | Use when no additional modifier applies and the service is furnished as described. |